- Telehealth Visits
- Insurance plan information
Ginger Cupit, DO
Family Medicine • Women's Health- Telehealth Visits
- Insurance plan information
Ginger Cupit, DO
Family Medicine • Women's Health- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Sports Medicine, American Board of Family Medicine
- Family Medicine, American Board of Family Medicine
Fellowship
- Sports Medicine, UCSF School of Medicine -GME
Residency
- Family Medicine, Georgetown Univ/Providence Hospital FP Residency
Internship
- Family Medicine, Georgetown Univ/Providence Hospital FP Residency
Degree
- DO, Oregon Health Sciences University - Ashland
My expertise
Specialties
- Family Medicine
- Women's Health
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223574%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223574%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 150 reviews
- March 25, 20265 out of 5 Stars
Dr Ginger is the best. Smart and easy to talk with about my concerns. Love seeing her and problem solving.
- March 19, 20265 out of 5 Stars
I highly respect Dr. Cupit. She's very caring, knowledgeable and approachable.I've already referred friends to her and they love her as much as I do.
- March 19, 20265 out of 5 Stars
Exceptional doctor!
- March 17, 20265 out of 5 Stars
Dr. Cupit is absolutely wonderful and listens well!!!
- March 4, 20265 out of 5 Stars
Very knowledgeable, kind, caring doctor.
- March 2, 20265 out of 5 Stars
Dr. Cupit is wonderful. Excellent practitioner and intentional caregiver! Would definitely recommend!
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.